Studies Tie Heart Drugs to Diabetes and Breast Cancer
Two separate studies have linked the heart drugs Lipitor (used to treat high cholesterol) and Digoxin (prescribed to patients with heart failure or abnormal heart beats) to higher risk of diabetes and breast cancer, respectively.
According to the Lipitor website, people with diabetes are advised to consult their doctor before starting Lipitor (known generically as Atorvastatin). And in 2008, research implicated Digoxin (marketed as Lanoxin and Digitek) with increased risk of breast cancer.
0 Comments | Continue reading...
Obesity Without Health Risks – Can It Be True?
Obesity has always been touted as one of the biggest controllable risk factors for heart disease and diabetes. While that's still true, researchers are discovering that a small portion of obese people manage to avoid the associated risks.
Conditions like high blood pressure and high cholesterol sometimes go hand in hand with obesity. Those conditions put a person in high cardiovascular risk.
But a recent Dutch study, presented at the Endocrine Society's annual meeting, found that 6.8 percent of obese study participants had no health history of cardiovascular disease or diabetes, had none of the conditions that put them at risk, and were basically "metabolically healthy."
Big Weight Loss Requires Big Changes
The "small changes" philosophy, touted by health experts and First Lady Michelle Obama alike, took a big hit this week in Tara Parker-Pope's Well Blog post, In Obesity Epidemic, What's One Cookie?.
Pope writes an essential truth the some health experts dodge, fearing it will scare people off: If you want to lose a significant amount of weight, you've got to give your lifestyle an extreme makeover.